Credit Suisse analyst Gautam Sawant raised the firm’s price target on CME Group to $207 from $198 and keeps an Outperform rating on the shares. The firm notes CME reported EPS of $1.92 above Credit Suisse’s estimates of $1.84 and consensus of $1.88, owing to revenues in-line with the firm’s estimates, operating expenses below its estimates and higher-than-expected non-operating income.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CME:
- CME Group Inc. Reports Fourth-Quarter and Full-Year 2022 Financial Results
- CME Group reports Q4 adjusted EPS $1.92, consensus $1.88
- CME Group price target raised to $198 from $192 at Credit Suisse
- CME Group raises quarterly dividend 10% to $1.10 from $1.00 per share
- CME Group Declares Quarterly Dividend
